Radioimmunoassay (RIA) is a highly sensitive in vitro technique developed to measure antigen concentrations in samples, notably introduced for insulin detection in 1960. The method relies on competitive binding between radiolabeled and unlabeled antigens with specific antibodies, allowing precise quantification of hormones and other substances. While RIA is widely used for its specificity and sensitivity in various clinical applications, it also poses radiation hazards and requires specialized training and equipment.